These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 11205685)

  • 41. [Clinical usefulness of the detection of mutations of the HFE gene in hemochromatosis].
    Oliva R; Sánchez M; Bruguera M; Rodés J
    Gastroenterol Hepatol; 2000 Nov; 23(9):433-5. PubMed ID: 11126040
    [No Abstract]   [Full Text] [Related]  

  • 42. The S65C mutation in Spain. Implications for iron overload screening.
    Remacha AF; Barceló MJ; Sardà MP; Blesa I; Altés A; Baiget M
    Haematologica; 2000 Dec; 85(12):1324-5. PubMed ID: 11114141
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Best practice guidelines for the molecular genetic diagnosis of Type 1 (HFE-related) hereditary haemochromatosis.
    King C; Barton DE
    BMC Med Genet; 2006 Nov; 7():81. PubMed ID: 17134494
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A PCR-SSP method for detecting the Cys282Tyr mutation in the HFE gene associated with hereditary haemochromatosis.
    Smillie D
    Mol Pathol; 1997 Oct; 50(5):275-6. PubMed ID: 9497921
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hereditary hemochromatosis in Spain.
    Sánchez M; Bruguera M; Quintero E; Barrio Y; Mazzara R; Rodés J; Oliva R
    Genet Test; 2000; 4(2):171-6. PubMed ID: 10953957
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Histological evaluation of iron in liver biopsies: relationship to HFE mutations.
    Brunt EM; Olynyk JK; Britton RS; Janney CG; Di Bisceglie AM; Bacon BR
    Am J Gastroenterol; 2000 Jul; 95(7):1788-93. PubMed ID: 10925986
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Polymorphism in intron 4 of HFE does not compromise haemochromatosis mutation results.
    Gomez PS; Parks S; Ries R; Tran TC; Gomez PF; Press RD
    Nat Genet; 1999 Nov; 23(3):272. PubMed ID: 10545944
    [No Abstract]   [Full Text] [Related]  

  • 48. [Diagnosis of haemochromatosis].
    IJsselstijn L; van Houten AA; Weerkamp F
    Ned Tijdschr Geneeskd; 2017; 161():D1438. PubMed ID: 29145899
    [TBL] [Abstract][Full Text] [Related]  

  • 49. HFE mutation analysis in patients with hepatitis C virus with positive screening for iron overload.
    Remacha AF; Carrasco M; Sardá MP; Barceló MJ; Baiget M
    Haematologica; 1999 Mar; 84(3):284-5. PubMed ID: 10189401
    [No Abstract]   [Full Text] [Related]  

  • 50. A pilot C282Y hemochromatosis screening in Italian newborns by TaqMan technology.
    Restagno G; Gomez AM; Sbaiz L; De Gobbi M; Roetto A; Bertino E; Fabris C; Fiorucci GC; Fortina P; Camaschella C
    Genet Test; 2000; 4(2):177-81. PubMed ID: 10953958
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Correlation between genotype and phenotype in hereditary hemochromatosis: analysis of 61 cases.
    Sham RL; Ou CY; Cappuccio J; Braggins C; Dunnigan K; Phatak PD
    Blood Cells Mol Dis; 1997 Aug; 23(2):314-20. PubMed ID: 9410475
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Genetic hemochromatosis and the HFE gene].
    Moirand R
    Bull Acad Natl Med; 2000; 184(2):325-35; discussion 335-6. PubMed ID: 10989541
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Polymorphism in intron 4 of HFE does not compromise haemochromatosis mutation results. The European Haemochromatosis Consortium.
    Merryweather-Clarke AT; Pointon JJ; Shearman JD; Robson KJ; Jouanolle AM; Mosser A; David V; Le Gall JY; Halsall DJ; Elsey TS; Kelly A; Cox TM; Clare M; Bomford A; Vandwalle JL; Rochette J; Borot N; Coppin H; Roth MP; Ryan E; Crowe J; Totaro A; Gasparini P; Roetto A; Walker AP
    Nat Genet; 1999 Nov; 23(3):271. PubMed ID: 10545942
    [No Abstract]   [Full Text] [Related]  

  • 54. Update on hereditary hemochromatosis and the HFE gene.
    Brandhagen DJ; Fairbanks VF; Batts KP; Thibodeau SN
    Mayo Clin Proc; 1999 Sep; 74(9):917-21. PubMed ID: 10488796
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Overestimation of HFE C282Y homozygous hemochromatosis prevalence as the result of a common primer-binding site polymorphism.
    Press RD
    Mol Diagn; 1999 Dec; 4(4):391-2. PubMed ID: 10671650
    [No Abstract]   [Full Text] [Related]  

  • 56. High incidence of the Cys 282 Tyr mutation in the HFE gene in the Irish population--implications for haemochromatosis.
    Murphy S; Curran MD; McDougall N; Callender ME; O'Brien CJ; Middleton D
    Tissue Antigens; 1998 Nov; 52(5):484-8. PubMed ID: 9864039
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genetic irony beyond haemochromatosis: clinical effects of HLA-H mutations.
    Beutler E
    Lancet; 1997 Feb; 349(9048):296-7. PubMed ID: 9024367
    [No Abstract]   [Full Text] [Related]  

  • 58. A cheaper and more rapid polymerase chain reaction-restriction fragment length polymorphism method for the detection of the HLA-H gene mutations occurring in hereditary hemochromatosis.
    Lynas C
    Blood; 1997 Nov; 90(10):4235-6. PubMed ID: 9354698
    [No Abstract]   [Full Text] [Related]  

  • 59. Large-scale screening for HFE mutations: methodology and cost.
    Beutler E; Gelbart T
    Genet Test; 2000; 4(2):131-42. PubMed ID: 10953952
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Increased risk of acute myocardial infarction in carriers of the hemochromatosis gene Cys282Tyr mutation : a prospective cohort study in men in eastern Finland.
    Tuomainen TP; Kontula K; Nyyssönen K; Lakka TA; Heliö T; Salonen JT
    Circulation; 1999 Sep; 100(12):1274-9. PubMed ID: 10491370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.